Snakebite
 envenoming is a common problem in many parts of the world, but little 
is known about its magnitude in the Arab countries of the Middle East, 
where cases are not widely reported.  
The
 aim is to halve the numbers of deaths and cases of disability due to 
snakebite envenoming over the next 12 years through a programme that 
targets affected communities and their health systems, and by ensuring 
access to safe, effective treatment through increased cooperation, 
collaboration and partnership at all levels.
An
 interdisciplinary group of zoologists and snakebite experts recently 
reviewed existing English and Arabic literature on terrestrial venomous 
snakes and snake bites in Arab countries of the Middle East providing an
 up to date and comprehensive view of the situation in the region. 
With
 a wide range of habitats, the review found that the region hosts 19 
species of terrestrial venomous snakes of varying medical importance. 
These include 14 viperids (excluding a very dubious record of 
Montivipera xanthina in Syria) (Photo 1), 3 elapids (Photo 2) and 2 atractaspidines. 

D.A. Warrell / Arabian cobra (Naja arabica) specimen from Saudi Arabia.
The
 review shows that available scientific literature is heterogeneous 
across the region, and that epidemiological and clinical data on 
snakebite are generally limited or even absent from some countries.Iraq,
 Jordan, Lebanon, Oman, Saudi Arabia, and Yemen report the largest 
numbers of snakebite cases (for example, a study in Saudi Arabia 
described 1,019 snakebite cases for the period 2005-2010), with common 
epidemiological patterns: males being predominantly bitten outdoors on 
their feet. On the other hand, only two snakebite case reports were 
found from Kuwait and no information was available from Qatar.
“
Countries
 in this region should be encouraged to make snake bites and scorpion 
stings notifiable diseases, and to record associated mortality and 
morbidity, so that the public health importance of these conditions can 
be more reliably assessed.” said Professor David Warrell of the University of Oxford, United Kingdom, who is the coordinating author of the study.
Antivenoms
There
 are only two antivenom producers in this region. The Scientific Studies
 & Research Centre SYRIA now manufactures only scorpion antivenom. 
Their “Polyvalent Anti snake Venom sera” is no longer obtainable. 
National Antivenom & Vaccine Production Center (NAThe Vice PresidentC), National 
Guard Health Affairs, Riyadh, Saudi Arabia, manufactures bivalent 
Naja/Walterinnesia Snake Antivenom, polyvalent Snake Antivenom, and polyvalent Scorpion Antivenom. 
Imported Indian Vins “Snake Venom Antitoxin (Biosnake)” is claimed to neutralise 
Naja haje, Naja nigricollis and 
Cerastes cerastes venoms,
 but the geographical origin of these venoms and the clinical 
effectiveness of the antivenom for snakebites in Arab countries is 
unproven.  
“
Current
 political turbulence in the region is jeopardising local production, 
and importation from adjacent Middle Eastern countries. It also makes 
the development of a coordinated regional initiative to overcome this 
deficiency far more difficult. Responsible international producers 
outside the region should consider developing appropriate antivenoms to 
meet the humanitarian need and marketing opportunity. However, new 
regional antivenoms must be designed based on sound knowledge of the 
species known to be of the greatest medical importance and raised using 
venoms obtained from snakes in Arab countries” said Professor Zuhair S. Amr, lead author, Jordan University for Science and Technology, Irbid, Jordan.
Adequate
 prevention and increased awareness of this public health problem in the
 region should also be promoted, particularly among farmers and other 
groups in rural areas and exposed to encounters with snakes in their 
everyday life.  
 
Snakebite envenoming is a common problem in many parts of the world, but little 
is known about its magnitude in the Arab countries of the Middle East, 
where cases are not widely reported.  The aim is to halve the numbers of deaths and cases of disability due to snakebite envenoming over the next 12 years through a programme that targets affected communities and their health systems, and by ensuring access to safe, effective treatment through increased cooperation, collaboration and partnership at all levels.
News (English) - World Health Organization
Corporate news releases, statements, and notes for media issued by the World Health Organization.
urn:uuid:ea8fa6f9-3d74-4876-923a-e6e9369680e8